NASDAQ:GNOM Global X Genomics & Biotechnology ETF (GNOM) Price, Holdings, & News → The 'Smart Money' Is Ready for May 1st Are You? (From Stansberry Research) (Ad) Free GNOM Stock Alerts $10.12 +0.23 (+2.33%) (As of 02:16 PM ET) Add Compare Share Share Today's Range$9.94▼$10.1850-Day Range$9.68▼$12.2952-Week Range$8.63▼$13.33Volume43,745 shsAverage Volume68,480 shsMarket Capitalization$92.29 millionAssets Under Management$90.27 millionDividend Yield0.00%Net Expense Ratio0.50% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Get Global X Genomics & Biotechnology ETF alerts: Email Address About Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.Read More GNOM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GNOM ETF News HeadlinesApril 18, 2024 | markets.businessinsider.comThe Analyst Landscape: 4 Takes On 10x GenomicsMarch 21, 2024 | investorplace.com3 Stocks That Could Be the Next Big Thing in Gene EditingApril 23, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.March 14, 2024 | finance.yahoo.comGlobal X Genomics & Biotechnology UCITS ETF (GNOG.L)March 6, 2024 | investing.comGlobal X Genomics & Biotechnology ETF (GNOM)December 29, 2023 | msn.comGlobal X Cannabis ETF declares $0.1656 dividendMay 12, 2023 | investing.comGlobal X S&P 500® Catholic Values ETF (CATH)April 29, 2023 | benzinga.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM), Quotes and News SummaryApril 23, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.April 15, 2023 | thestreet.comComplete Genomics Stock Falls On Unusually High Volume (GNOM)See More Headlines Receive GNOM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerGlobal X Fund NameGlobal X Genomics & Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:GNOM Inception Date4/5/2019 Fund ManagerChang Kim, James Ong, Nam To, Wayne Xie Webwww.completegenomics.com Phone+1-650-9432800Fund Focus Asset ClassEquity BenchmarkSolactive Genomics Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings44 Fund Statistics Assets Under Management$90.27 million Average Daily Volume$0.00 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorGlobal X Management Company LLC AdvisorGlobal X Management Company LLC CustodianBrown Brothers Harriman & Co. DistributorSEI Investments Distribution Co. Transfer AgentBrown Brothers Harriman & Co. TrusteeN/A Lead Market MakerSusquehanna Options OptionableOptionable Options Volume1 Put Options1 Call Options1 Short Interest11,000 shs Miscellaneous Outstanding Shares9,120,000Beta1.30 Creation Unit50,000 Creation Fee$500.00 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Ad Behind the MarketsPentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>> Global X Genomics & Biotechnology ETF ExpensesTypeGNOMTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.50%0.57%0.54%0.48%0.51%Other Expenses0.00%0.72%0.54%0.34%0.58%Total Expense0.50%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.76%-0.55%-0.22%-0.57%Net Expense0.50%0.59%0.60%0.54%0.58% Global X Genomics & Biotechnology ETF (GNOM) Holdings & ExposureTop 10 GNOM HoldingsNatera(NASDAQ:NTRA)Holding Weight: 8.02%CRISPR Therapeutics(NASDAQ:CRSP)Holding Weight: 5.28%Moderna(NASDAQ:MRNA)Holding Weight: 4.89%Ultragenyx Pharmaceutical(NASDAQ:RARE)Holding Weight: 4.86%Agilent Technologies(NYSE:A)Holding Weight: 4.72%BioMarin Pharmaceutical(NASDAQ:BMRN)Holding Weight: 4.05%Sarepta Therapeutics(NASDAQ:SRPT)Holding Weight: 3.99%Qiagen(NYSE:QGEN)Holding Weight: 3.82%Illumina(NASDAQ:ILMN)Holding Weight: 3.76%Bio-Techne(NASDAQ:TECH)Holding Weight: 3.74%GNOM Sector ExposureGNOM Industry ExposureFull Holdings Details Similar ETFsVanEck Digital Transformation ETFNASDAQ:DAPPWisdomTree Cybersecurity FundNASDAQ:WCBRFirst Trust Indxx Innovative Transaction & Process ETFNASDAQ:LEGRVictoryShares THB Mid Cap ESG ETFNASDAQ:MDCPWahed Dow Jones Islamic World ETFNASDAQ:UMMAInstitutional OwnershipRaymond James Financial Services Advisors Inc.Bought 12,342 shares on 4/23/2024Ownership: 2.887%Centaurus Financial Inc.Bought 1,624 shares on 2/26/2024Ownership: 0.155%James J. Burns & Company LLCBought 4,848 shares on 2/13/2024Ownership: 0.225%Manhattan West Asset Management LLCSold 83,405 shares on 2/12/2024Ownership: 0.460%One Capital Management LLCSold 33,930 shares on 2/7/2024Ownership: 6.152%View All Institutional Transactions GNOM ETF - Frequently Asked Questions How have GNOM shares performed in 2024? Global X Genomics & Biotechnology ETF's stock was trading at $11.56 on January 1st, 2024. Since then, GNOM stock has decreased by 12.0% and is now trading at $10.17. View the best growth stocks for 2024 here. What does GNOM invest in? Global X Genomics & Biotechnology ETF is a equity fund issued by Global X. GNOM focuses on theme investments and follows the Solactive Genomics Index. The fund's investments total to approximately $90.27 million assets under management. What stocks does Global X Genomics & Biotechnology ETF hold? GNOM invests in 44 holdings. Some of the stocks in their portfolio include Natera (NTRA), CRISPR Therapeutics (CRSP), Moderna (MRNA), Ultragenyx Pharmaceutical (RARE), Agilent Technologies (A), BioMarin Pharmaceutical (BMRN), Sarepta Therapeutics (SRPT), Qiagen (QGEN), Illumina (ILMN) and Bio-Techne (TECH). What is the management fee for Global X Genomics & Biotechnology ETF? Global X Genomics & Biotechnology ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for GNOM is 0.50%. What other stocks do shareholders of Global X Genomics & Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Global X Genomics & Biotechnology ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), Quest Diagnostics (DGX), Micron Technology (MU), Dynavax Technologies (DVAX), Matinas BioPharma (MTNB). Who are Global X Genomics & Biotechnology ETF's major shareholders? Global X Genomics & Biotechnology ETF's stock is owned by many different institutional and retail investors. Top institutional investors include Raymond James Financial Services Advisors Inc. (2.89%). How do I buy shares of Global X Genomics & Biotechnology ETF? Shares of GNOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GNOM) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.